(Q54508172)

30 May 2018

title

Metformin interacts with AMPK through binding to γ subunit. (English)

1 reference

30 May 2018

1 reference

Yaya Zhang

1

1 reference

30 May 2018

Yongjun Wang

2

1 reference

30 May 2018

Chuanen Bao

3

1 reference

30 May 2018

Yingyi Xu

4

1 reference

30 May 2018

Huili Shen

5

1 reference

30 May 2018

Junjie Chen

6

1 reference

30 May 2018

Jianghua Yan

7

1 reference

30 May 2018

Yuqiang Chen

8

1 reference

30 May 2018

publication date

30 May 2012

1 reference

30 May 2018

Molecular and Cellular Biochemistry

published in

1 reference

30 May 2018

volume

368

1 reference

30 May 2018

issue

1-2

1 reference

30 May 2018

page(s)

69-76

1 reference

30 May 2018

https://scigraph.springernature.com/pub.10.1007/s11010-012-1344-5

exact match

0 references

cites work

Effects of troglitazone and metformin on glucose and lipid metabolism: alterations of two distinct molecular pathways

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1344-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1344-5

Mechanism by which metformin reduces glucose production in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1344-5

Metformin and reduced risk of cancer in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1344-5

Metformin and cancer: new applications for an old drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1344-5

Metformin: a therapeutic opportunity in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1344-5

Role of AMP-activated protein kinase in mechanism of metformin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1344-5

AMPK: an emerging drug target for diabetes and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1344-5

Mammalian AMP-activated protein kinase subfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1344-5

The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1344-5

The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1344-5

Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1344-5

LKB1/AMPK/mTOR signaling pathway in hematological malignancies: from metabolism to cancer cell biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1344-5

The LKB1 complex-AMPK pathway: the tree that hides the forest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1344-5

The AMP-activated protein kinase--fuel gauge of the mammalian cell?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1344-5

Dual regulation of the AMP-activated protein kinase provides a novel mechanism for the control of creatine kinase in skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1344-5

AMPK and the biochemistry of exercise: implications for human health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1344-5

AMPK in Health and Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1344-5

Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1344-5

Adiponectin suppresses gluconeogenic gene expression in mouse hepatocytes independent of LKB1-AMPK signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1344-5

The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1344-5

The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1344-5

Rational discovery of novel nuclear hormone receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1344-5

Improved docking, screening and selectivity prediction for small molecule nuclear receptor modulators using conformational ensembles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1344-5

Mechanism of interaction between human serum albumin and N-alkyl phenothiazines studied using spectroscopic methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1344-5

2-Deoxy-D-glucose treatment of endothelial cells induces autophagy by reactive oxygen species-mediated activation of the AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1344-5

Variation in genes coding for AMP-activated protein kinase (AMPK) and breast cancer risk in the European Prospective Investigation on Cancer (EPIC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1344-5

Discovery of diverse thyroid hormone receptor antagonists by high-throughput docking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1344-5

Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1344-5

Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1344-5

Metformin: its emerging role in oncology

21 January 2018

1 reference

12 December 2020

Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells

1 reference

12 December 2020

Metformin increases insulin-stimulated glucose transport in insulin-resistant human skeletal muscle

1 reference

12 December 2020

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: Response to Farooki and Schneider

1 reference

12 December 2020

Metformin and contrast media: where is the conflict?

1 reference

12 December 2020

Soft docking an L and a D peptide to an anticholera toxin antibody using internal coordinate mechanics

1 reference

12 December 2020

AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle

1 reference

12 December 2020

10.1007/S11010-012-1344-5

Identifiers

DOI

1 reference

30 May 2018

1 reference

30 May 2018